Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Clinical trial NCT03459079 · COMPLETED

Trial details

NCT number: NCT03459079
Sponsor: University of Florida
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease (NAFLD)Type 2 Diabetes (T2DM)

Start date: 2018-08-14
Primary completion: 2023-04-18
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.